ANRO Stock Earnings: Alto Neuroscience Misses EPS for Q1 2024 Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday More Articles Select Price, Percent change, or Dollar change as the y-axis. Price Select Area, Line, OHLC or Candlestick as the chart type. ...
Alto Neuroscience is a clinical-stage biopharmaceutical company that integrates the biology of the patient into drug development to improve the lives of people with mental health conditions. Through its AI-enabled biomarker platform, Alto Neuroscience combines rich sources of information on patients’ bra...